John Galatowitsch, MD

University of Colorado School of Medicine

Poster(s):

• D0385 - Ustekinumab versus Tofacitinib as Second-Line Therapy for Ulcerative Colitis: A Retrospective, Observational Study
  Tuesday, October 25, 2022

  10:00 AM – 12:00 PM ET